Login / Signup

Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques.

Rong LiXiancai MaJieyi DengQier ChenWeiwei LiuZhilin PengYidan QiaoYingtong LinXin HeHui Zhang
Published in: Cellular & molecular immunology (2021)
Keyphrases
  • sars cov
  • iron oxide
  • wild type